Fludroxycortidum [INN-Latin] en es it fr

Fludroxycortidum [INN-Latin] Brand names, Fludroxycortidum [INN-Latin] Analogs

Fludroxycortidum [INN-Latin] Brand Names Mixture

  • No information avaliable

Fludroxycortidum [INN-Latin] Chemical_Formula


Fludroxycortidum [INN-Latin] RX_link


Fludroxycortidum [INN-Latin] fda sheet

Fludroxycortidum [INN-Latin] msds (material safety sheet)

Fludroxycortidum [INN-Latin] Synthesis Reference

No information avaliable

Fludroxycortidum [INN-Latin] Molecular Weight

436.514 g/mol

Fludroxycortidum [INN-Latin] Melting Point

251 oC

Fludroxycortidum [INN-Latin] H2O Solubility


Fludroxycortidum [INN-Latin] State


Fludroxycortidum [INN-Latin] LogP


Fludroxycortidum [INN-Latin] Dosage Forms


Fludroxycortidum [INN-Latin] Indication

For relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, particularly dry, scaling localized lesions

Fludroxycortidum [INN-Latin] Pharmacology

No information avaliable

Fludroxycortidum [INN-Latin] Absorption

Once absorbed through the skin, topical corticosteroids are handled through pharmacokinetic pathways similar to those of systemically administered corticosteroids

Fludroxycortidum [INN-Latin] side effects and Toxicity

Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary- adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria in some patients

Fludroxycortidum [INN-Latin] Patient Information

Fludroxycortidum [INN-Latin] Organisms Affected

Humans and other mammals